Chugai Pharma conducts digital transformation for manufacturing function

Chugai Pharmaceutical Co., Ltd. on Jan 12, 2021, announced its digital transformation (DX) for manufacturing functi...

January 14, 2021 | Thursday | News
Jumpstart Cell & Gene Therapy Commercialization with SUT Learning

The FDA’s approvals of more cell and gene therapies (CGTs) are cause for celebration — but the marathon is n...

April 2, 2021 | Friday | Opinion
KSQ Therapeutics and Takeda to develop and market novel Immuno-Oncology therapies

KSQ Therapeutics, a biotechnology company using its proprietary CRISPRomics® discovery platform to systematically sc...

January 14, 2021 | Thursday | News
BeiGene inks deal with Novartis to jointly develop oncology drug

BeiGene, Ltd, a China based commercial-stage biotechnology company focused on developing and commercialising innovative ...

January 12, 2021 | Tuesday | News
Driving laboratory efficiency with Data Intelligence: Expert Opinion

Pharmaceutical companies are poised for significant growth within the Asia Pacific region, with projections estimated as...

December 1, 2020 | Tuesday | Regulatory
Antengene's integrated APAC platform to develop innovative oncology therapies

Antengene Corporation Limited, a clinical-stage biopharmaceutical company with integrated drug discovery, clinical devel...

November 24, 2020 | Tuesday | News
Thermo Fisher to establish new pharma services facility in China

Thermo Fisher Scientific Inc. has signed a joint venture agreement to establish a new pharma services facility in H...

November 6, 2020 | Friday | News
Humanigen extends to APAC market with COVID-19 drug

US based Humanigen, Inc., a clinical stage biopharmaceutical company focused on preventing and treating an immune hyper-...

November 5, 2020 | Thursday | News